GLATIRAMER ACETATE

GLATIRAMER ACETATE was reported 59611 times

GLATIRAMER ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMEDIATE POST-INJECTION REACTION 827 0.7518
1 MULTIPLE SCLEROSIS PLAQUE 17 0.5312
2 LIPOATROPHY 239 0.2511
3 NEEDLE FATIGUE 92 0.2013
4 INJECTION SITE ATROPHY 325 0.1974
5 INJECTION SITE NECROSIS 386 0.1893
6 PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS 16 0.1290
7 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 61 0.1260
8 EMBOLIA CUTIS MEDICAMENTOSA 90 0.1131
9 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 197 0.1047
10 WRONG DEVICE USED 62 0.0945
11 PROGRESSIVE MULTIPLE SCLEROSIS 102 0.0883
12 INJECTION SITE SCAR 239 0.0838
13 RELAPSING-REMITTING MULTIPLE SCLEROSIS 69 0.0799
14 MULTIPLE SCLEROSIS RELAPSE 5187 0.0756
15 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 245 0.0738
16 RELAPSING MULTIPLE SCLEROSIS 22 0.0728
17 INJECTION SITE SCAB 66 0.0685
18 SKIN INDENTATION 32 0.0678
19 INJECTION RELATED REACTION 111 0.0672
20 MAGNETIC RESONANCE IMAGING ABNORMAL 80 0.0669
21 INJECTION SITE EROSION 23 0.0653
22 MULTIPLE SCLEROSIS 3103 0.0648
23 HEMIPARAESTHESIA 25 0.0641
24 INJECTION SITE INDENTATION 136 0.0627
25 INJECTION SITE MASS 2076 0.0561
26 JC VIRUS TEST POSITIVE 44 0.0523
27 INJECTION SITE REACTION 3513 0.0510
28 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 63 0.0505
29 GAIT SPASTIC 17 0.0496
30 JC POLYOMAVIRUS TEST POSITIVE 56 0.0478
31 BAND SENSATION 60 0.0473
32 CENTRAL NERVOUS SYSTEM LESION 638 0.0464
33 LIPODYSTROPHY ACQUIRED 96 0.0452
34 INJECTION SITE URTICARIA 1062 0.0432
35 INJECTION SITE ULCER 37 0.0392
36 JC VIRUS INFECTION 58 0.0362
37 INJECTION SITE INFECTION 115 0.0350
38 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 78 0.0328
39 OPTIC NEURITIS 291 0.0320
40 INJECTION SITE INDURATION 399 0.0307
41 LACK OF INJECTION SITE ROTATION 53 0.0303
42 PERONEAL NERVE PALSY 172 0.0302
43 INJECTION SITE INFLAMMATION 139 0.0279
44 NORMAL NEWBORN 146 0.0268
45 INJECTION SITE HYPOAESTHESIA 38 0.0265
46 DEMYELINATION 102 0.0249
47 INJECTION SITE CELLULITIS 46 0.0247
48 INJECTION SITE OEDEMA 42 0.0244
49 BLADDER DYSFUNCTION 25 0.0243
50 MOTOR DYSFUNCTION 245 0.0240
51 WALKING AID USER 154 0.0233
52 INJECTION SITE DISCOLOURATION 291 0.0233
53 HEMIANAESTHESIA 18 0.0226
54 INJECTION SITE SWELLING 1715 0.0224
55 INJECTION SITE PRURITUS 1495 0.0223
56 DRUG ADMINISTERED IN WRONG DEVICE 21 0.0215
57 MUSCLE SPASTICITY 256 0.0208
58 TRIGEMINAL NEURALGIA 82 0.0204
59 NEUROGENIC BLADDER 42 0.0199
60 INJECTION SITE ERYTHEMA 2466 0.0199
61 INJECTION SITE VESICLES 120 0.0198
62 WHEELCHAIR USER 85 0.0191
63 NECROSIS 106 0.0190
64 THERAPY CHANGE 187 0.0190
65 INJECTION SITE IRRITATION 234 0.0184
66 INJECTION SITE PARAESTHESIA 28 0.0182
67 INJECTION SITE WARMTH 364 0.0177
68 THROAT TIGHTNESS 470 0.0174
69 INJECTION SITE ABSCESS 43 0.0173
70 INJECTION SITE HYPERSENSITIVITY 54 0.0173
71 FEAR OF INJECTION 121 0.0169
72 PARAPARESIS 30 0.0168
73 WHITE MATTER LESION 21 0.0166
74 NEAR DEATH EXPERIENCE 54 0.0163
75 MYELITIS TRANSVERSE 23 0.0163
76 INJECTION SITE PAIN 4956 0.0161
77 INJECTION SITE INJURY 89 0.0160
78 FLUSHING 1569 0.0154
79 FINE MOTOR SKILL DYSFUNCTION 44 0.0152
80 SENSORY LOSS 122 0.0151
81 INJECTION SITE BRUISING 1174 0.0147
82 LIVE BIRTH 123 0.0147
83 VASCULAR INJURY 21 0.0145
84 INJECTION SITE DISCOMFORT 150 0.0142
85 BLADDER DISORDER 138 0.0139
86 MUSCLE CONTRACTURE 28 0.0138
87 BALANCE DISORDER 1191 0.0138
88 ANAPHYLACTIC SHOCK 355 0.0138
89 HEMIPARESIS 229 0.0135
90 SKIN NECROSIS 70 0.0135
91 INJECTION SITE NODULE 147 0.0133
92 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 108 0.0131
93 ADVERSE REACTION 166 0.0125
94 MONOPLEGIA 54 0.0124
95 ABASIA 307 0.0124
96 SKIN REACTION 175 0.0124
97 INDURATION 22 0.0123
98 MATERNAL EXPOSURE DURING BREAST FEEDING 50 0.0123
99 GENERALISED ERYTHEMA 70 0.0123
100 OPHTHALMOPLEGIA 19 0.0120
101 CHILLS 1405 0.0120
102 PHARYNGEAL PARAESTHESIA 19 0.0120
103 DEVICE MECHANICAL ISSUE 163 0.0119
104 ATROPHY 23 0.0118
105 THERAPY CESSATION 605 0.0118
106 HYPOAESTHESIA 1751 0.0117
107 PARALYSIS 166 0.0116
108 SKIN INDURATION 24 0.0116
109 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 57 0.0114
110 FEELING COLD 316 0.0113
111 HEAT STROKE 17 0.0112
112 GAIT DISTURBANCE 2124 0.0111
113 DYSGRAPHIA 73 0.0111
114 MYELITIS 17 0.0110
115 FEELING HOT 663 0.0108
116 INJECTION SITE HAEMATOMA 156 0.0107
117 CHOKING SENSATION 59 0.0107
118 TUNNEL VISION 20 0.0107
119 MUSCLE TIGHTNESS 171 0.0105
120 INJECTION SITE RASH 320 0.0104
121 SPINAL CORD DISORDER 17 0.0103
122 TEMPERATURE INTOLERANCE 105 0.0102
123 URTICARIA 1703 0.0102
124 FUNCTIONAL GASTROINTESTINAL DISORDER 35 0.0101
125 SKIN MASS 67 0.0100
126 CHEST DISCOMFORT 1025 0.0100
127 SENSORY DISTURBANCE 159 0.0099
128 LOSS OF CONTROL OF LEGS 37 0.0098
129 ECTOPIC PREGNANCY 30 0.0097
130 PHARYNGEAL OEDEMA 149 0.0097
131 CORONAVIRUS INFECTION 64 0.0097
132 INFLUENZA LIKE ILLNESS 777 0.0094
133 SUFFOCATION FEELING 23 0.0093
134 DIPLEGIA 18 0.0091
135 EXPOSURE VIA BREAST MILK 36 0.0090
136 HYPERTONIC BLADDER 26 0.0090
137 EAR SWELLING 19 0.0090
138 MUSCULAR WEAKNESS 1017 0.0089
139 APPARENT DEATH 32 0.0089
140 MONOPARESIS 16 0.0088
141 SEIZURE LIKE PHENOMENA 15 0.0088
142 LIMB DISCOMFORT 272 0.0088
143 COORDINATION ABNORMAL 121 0.0087
144 MICTURITION URGENCY 98 0.0086
145 ASPHYXIA 70 0.0086
146 GENERAL SYMPTOM 64 0.0085
147 HEMIPLEGIA 71 0.0085
148 PARESIS 19 0.0085
149 MOVEMENT DISORDER 272 0.0085
150 SCAR 144 0.0084
151 DIPLOPIA 218 0.0084
152 CARDIAC FLUTTER 54 0.0083
153 SWELLING FACE 542 0.0083
154 INJECTION SITE EXTRAVASATION 102 0.0083
155 COGNITIVE DISORDER 381 0.0082
156 DECREASED INTEREST 48 0.0081
157 WALKING DISABILITY 17 0.0081
158 CLUMSINESS 22 0.0081
159 CAESAREAN SECTION 93 0.0080
160 PALPITATIONS 935 0.0080
161 LIP SWELLING 265 0.0079
162 INJECTION SITE HAEMORRHAGE 635 0.0079
163 ANAPHYLACTIC REACTION 434 0.0078
164 BURNING SENSATION 549 0.0078
165 IMMOBILE 34 0.0078
166 ANAL INCONTINENCE 70 0.0078
167 INFECTION SUSCEPTIBILITY INCREASED 17 0.0078
168 FAECAL INCONTINENCE 37 0.0077
169 MEMORY IMPAIRMENT 1057 0.0077
170 URINARY INCONTINENCE 227 0.0077
171 ADVERSE EVENT 705 0.0076
172 HEAD DISCOMFORT 135 0.0076
173 INCONTINENCE 80 0.0076
174 FALL 2506 0.0075
175 PARAESTHESIA 1177 0.0075
176 NEEDLE ISSUE 217 0.0074
177 INJECTION SITE DISCHARGE 40 0.0074
178 MATERNAL EXPOSURE DURING PREGNANCY 657 0.0074
179 HYPERSENSITIVITY 1364 0.0073
180 SPINAL PAIN 86 0.0073
181 ATAXIA 87 0.0073
182 PARAPLEGIA 21 0.0073
183 DYSSTASIA 211 0.0072
184 TREMOR 1198 0.0072
185 GAIT INABILITY 241 0.0072
186 DYSAESTHESIA 22 0.0072
187 FEELING OF BODY TEMPERATURE CHANGE 42 0.0072
188 MASS 100 0.0071
189 FEAR OF DEATH 16 0.0071
190 MUSCLE CONTRACTIONS INVOLUNTARY 25 0.0071
191 EYE CONTUSION 15 0.0071
192 INVASIVE DUCTAL BREAST CARCINOMA 19 0.0070
193 EXPOSURE DURING BREAST FEEDING 23 0.0069
194 EYE MOVEMENT DISORDER 47 0.0069
195 PHARYNGEAL SWELLING 67 0.0068
196 CEREBRAL ATROPHY 27 0.0068
197 MOBILITY DECREASED 485 0.0067
198 SPEECH DISORDER 353 0.0067
199 MATERNAL EXPOSURE BEFORE PREGNANCY 46 0.0067
200 LOSS OF CONSCIOUSNESS 858 0.0067
201 HYPOKINESIA 97 0.0067
202 PREGNANCY 133 0.0066
203 HYSTERECTOMY 56 0.0065
204 MOUTH SWELLING 37 0.0064
205 ANKLE FRACTURE 97 0.0063
206 VEIN DISORDER 31 0.0062
207 INCORRECT DOSE ADMINISTERED BY DEVICE 162 0.0062
208 PRESYNCOPE 148 0.0061
209 NEURALGIA 148 0.0061
210 CONVULSION 348 0.0061
211 CONCUSSION 47 0.0061
212 HYPOAESTHESIA ORAL 91 0.0060
213 URINARY TRACT DISORDER 27 0.0060
214 HANGOVER 21 0.0060
215 ADVERSE DRUG REACTION 535 0.0060
216 LYMPHADENOPATHY 209 0.0059
217 LIGAMENT RUPTURE 26 0.0059
218 APHASIA 177 0.0059
219 SWOLLEN TONGUE 182 0.0058
220 ABORTION SPONTANEOUS 232 0.0058
221 DECUBITUS ULCER 47 0.0058
222 DYSPHEMIA 25 0.0057
223 BLINDNESS UNILATERAL 80 0.0057
224 UTERINE LEIOMYOMA 41 0.0056
225 CHEST PAIN 1031 0.0056
226 BLINDNESS TRANSIENT 41 0.0056
227 BEDRIDDEN 73 0.0055
228 URINARY TRACT INFECTION 944 0.0055
229 HYPOTHERMIA 56 0.0055
230 CYSTITIS 176 0.0055
231 MALIGNANT MELANOMA 74 0.0055
232 HYPERVENTILATION 32 0.0055
233 MUSCLE SPASMS 1010 0.0055
234 HYPOPNOEA 19 0.0055
235 SARCOIDOSIS 26 0.0055
236 AUTOIMMUNE HEPATITIS 38 0.0055
237 SKIN DISORDER 182 0.0055
238 THYROID NEOPLASM 15 0.0054
239 HEAD INJURY 172 0.0054
240 MUSCLE FATIGUE 23 0.0054
241 EXPIRED DEVICE USED 18 0.0054
242 SKIN INJURY 18 0.0054
243 SHOULDER OPERATION 23 0.0054
244 PRURITUS GENERALISED 115 0.0053
245 JOINT LOCK 15 0.0053
246 ERYTHEMA 1086 0.0053
247 CHOKING 103 0.0053
248 FACIAL BONES FRACTURE 19 0.0053
249 NYSTAGMUS 28 0.0053
250 MUSCULOSKELETAL DISORDER 100 0.0052
251 HYPERAESTHESIA 43 0.0052
252 VIITH NERVE PARALYSIS 18 0.0052
253 GALLBLADDER OPERATION 21 0.0052
254 MUSCULOSKELETAL STIFFNESS 454 0.0052
255 CONTUSION 498 0.0052
256 THERAPEUTIC RESPONSE UNEXPECTED 232 0.0052
257 HEART RATE INCREASED 512 0.0052
258 DYSPNOEA 2919 0.0052
259 FACIAL PAIN 46 0.0051
260 LOWER LIMB FRACTURE 99 0.0051
261 PANIC ATTACK 187 0.0051
262 FEAR 138 0.0051
263 PANIC REACTION 37 0.0051
264 VISUAL IMPAIRMENT 635 0.0051
265 NONSPECIFIC REACTION 28 0.0051
266 BODY TEMPERATURE INCREASED 104 0.0051
267 NON-CARDIAC CHEST PAIN 16 0.0051
268 LIGAMENT SPRAIN 50 0.0051
269 GESTATIONAL DIABETES 24 0.0050
270 DRUG DOSE OMISSION 819 0.0049
271 INCORRECT DRUG ADMINISTRATION RATE 21 0.0049
272 SPINAL FUSION SURGERY 20 0.0049
273 FACIAL PARALYSIS 42 0.0049
274 VERTIGO 300 0.0049
275 LYMPHOCYTE COUNT DECREASED 87 0.0049
276 INTERVERTEBRAL DISC DISORDER 21 0.0049
277 DEPRESSION 1118 0.0049
278 SENSATION OF HEAVINESS 19 0.0049
279 CYANOSIS 77 0.0049
280 DYSARTHRIA 181 0.0048
281 LACERATION 45 0.0048
282 AUTOIMMUNE THYROIDITIS 18 0.0048
283 PHOTOPSIA 30 0.0047
284 FRUSTRATION 17 0.0047
285 FORMICATION 33 0.0047
286 FACE INJURY 18 0.0047
287 SWELLING 443 0.0047
288 DEVICE DEFECTIVE 82 0.0047
289 MUSCLE TWITCHING 109 0.0047
290 PANIC DISORDER 18 0.0046
291 PARAESTHESIA ORAL 67 0.0046
292 INSURANCE ISSUE 71 0.0046
293 BLINDNESS 189 0.0046
294 HYPERHIDROSIS 596 0.0046
295 CEREBRAL DISORDER 34 0.0046
296 LYMPHOMA 71 0.0046
297 KIDNEY INFECTION 90 0.0046
298 MUSCLE ATROPHY 58 0.0046
299 DRUG INTOLERANCE 440 0.0046
300 MATERNAL EXPOSURE TIMING UNSPECIFIED 17 0.0045
301 LYMPHOPENIA 64 0.0045
302 INJURY ASSOCIATED WITH DEVICE 92 0.0045
303 PERIPHERAL COLDNESS 62 0.0045
304 HEPATIC NECROSIS 17 0.0045
305 SCAB 51 0.0045
306 VAGINAL INFECTION 21 0.0045
307 THYROID MASS 17 0.0044
308 COLD SWEAT 78 0.0044
309 DEFAECATION URGENCY 31 0.0044
310 SEIZURE 511 0.0044
311 IMMUNOSUPPRESSION 39 0.0044
312 B-CELL LYMPHOMA 15 0.0044
313 VITAMIN D DEFICIENCY 43 0.0044
314 HYPOTONIA 44 0.0044
315 INTERVERTEBRAL DISC PROTRUSION 96 0.0044
316 ANAPHYLACTOID REACTION 18 0.0044
317 CIRCULATORY COLLAPSE 74 0.0043
318 DEVICE USE ISSUE 76 0.0043
319 LYMPHOEDEMA 30 0.0043
320 FEELING ABNORMAL 1035 0.0043
321 GRIP STRENGTH DECREASED 38 0.0043
322 VISUAL FIELD DEFECT 31 0.0043
323 SKIN DISCOLOURATION 197 0.0043
324 RIB FRACTURE 88 0.0043
325 LIP OEDEMA 18 0.0042
326 DEVICE ISSUE 379 0.0042
327 FATIGUE 3278 0.0042
328 APPENDICECTOMY 15 0.0042
329 GOITRE 17 0.0041
330 AMNESIA 270 0.0041
331 DISABILITY 82 0.0041
332 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 292 0.0041
333 CERVIX CARCINOMA 16 0.0041
334 VITAMIN D DECREASED 35 0.0041
335 HOT FLUSH 308 0.0041
336 MUSCLE DISORDER 33 0.0041
337 TREATMENT FAILURE 334 0.0040
338 TENDERNESS 42 0.0040
339 IMMUNE SYSTEM DISORDER 53 0.0040
340 CHRONIC LYMPHOCYTIC LEUKAEMIA 19 0.0040
341 SKIN ATROPHY 23 0.0040
342 BACK PAIN 918 0.0039
343 THERMAL BURN 28 0.0039
344 ASTHENIA 1469 0.0039
345 PAIN IN EXTREMITY 1142 0.0039
346 MIGRAINE 368 0.0039
347 FRUSTRATION TOLERANCE DECREASED 31 0.0038
348 ABORTION INDUCED 36 0.0038
349 PARTIAL SEIZURES 20 0.0038
350 RASH GENERALISED 98 0.0038
351 HYPERPYREXIA 16 0.0038
352 DIZZINESS 1881 0.0038
353 POST PROCEDURAL COMPLICATION 72 0.0037
354 MACULAR OEDEMA 21 0.0037
355 ENERGY INCREASED 22 0.0037
356 STILLBIRTH 18 0.0037
357 SLUGGISHNESS 38 0.0037
358 FACE OEDEMA 61 0.0036
359 MUSCULOSKELETAL DISCOMFORT 62 0.0036
360 NECK PAIN 201 0.0036
361 EYE SWELLING 133 0.0036
362 GRAND MAL CONVULSION 33 0.0036
363 SPINAL OPERATION 44 0.0036
364 URINARY RETENTION 119 0.0036
365 UPPER LIMB FRACTURE 71 0.0036
366 JOINT INJURY 76 0.0036
367 OVERWEIGHT 19 0.0035
368 NEPHROLITHIASIS 162 0.0035
369 ESCHERICHIA URINARY TRACT INFECTION 15 0.0035
370 SYNCOPE 353 0.0035
371 RESTLESS LEGS SYNDROME 64 0.0035
372 GUILLAIN-BARRE SYNDROME 17 0.0035
373 PRODUCT SUBSTITUTION ISSUE 202 0.0035
374 PRODUCT DOSE OMISSION 229 0.0035
375 EAR DISCOMFORT 36 0.0035
376 OVARIAN CYST 35 0.0035
377 IMMUNE THROMBOCYTOPENIA 16 0.0035
378 VISION BLURRED 479 0.0035
379 DEPRESSED MOOD 184 0.0035
380 ASTHENOPIA 19 0.0035
381 POLLAKIURIA 144 0.0034
382 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 165 0.0034
383 FOOT FRACTURE 65 0.0034
384 MAJOR DEPRESSION 25 0.0034
385 MELANOCYTIC NAEVUS 15 0.0034
386 WRIST FRACTURE 41 0.0034
387 GROIN PAIN 30 0.0034
388 HEPATIC ENZYME ABNORMAL 17 0.0034
389 ANXIETY 969 0.0034
390 BIPOLAR DISORDER 37 0.0034
391 SKIN TIGHTNESS 16 0.0034
392 SPINAL COLUMN STENOSIS 16 0.0034
393 THINKING ABNORMAL 63 0.0034
394 SYRINGE ISSUE 59 0.0034
395 OVARIAN CANCER 31 0.0034
396 DRUG TOLERANCE 17 0.0034
397 PREMATURE LABOUR 19 0.0034
398 SKIN SWELLING 29 0.0033
399 PAIN 2041 0.0033
400 SENSATION OF FOREIGN BODY 28 0.0033
401 DEVICE BREAKAGE 134 0.0033
402 DEVICE LEAKAGE 143 0.0033
403 WOUND 92 0.0033
404 FOETAL GROWTH RESTRICTION 20 0.0033
405 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 111 0.0033
406 EAR DISORDER 15 0.0033
407 DEAFNESS UNILATERAL 18 0.0033
408 SKIN WARM 19 0.0033
409 BRAIN NEOPLASM 30 0.0033
410 DENTAL CARIES 36 0.0033
411 CELLULITIS 164 0.0033
412 MENISCUS INJURY 20 0.0032
413 NERVE INJURY 36 0.0032
414 HERPES ZOSTER 186 0.0032
415 GASTROINTESTINAL INFECTION 29 0.0032
416 FEELING DRUNK 24 0.0032
417 DISCOMFORT 197 0.0032
418 EYE DISORDER 106 0.0032
419 PERFORMANCE STATUS DECREASED 15 0.0032
420 APNOEA 25 0.0032
421 TIBIA FRACTURE 15 0.0032
422 ERYSIPELAS 16 0.0032
423 ACTIVITIES OF DAILY LIVING IMPAIRED 63 0.0032
424 MUSCLE RIGIDITY 38 0.0032
425 SKIN ABRASION 15 0.0032
426 SPINAL DISORDER 30 0.0032
427 THYROID CANCER 38 0.0032
428 CHOLECYSTECTOMY 36 0.0031
429 ENDOMETRIOSIS 15 0.0031
430 SCRATCH 33 0.0031
431 RESPIRATORY ARREST 86 0.0031
432 PRURITUS 1195 0.0031
433 GASTROENTERITIS VIRAL 56 0.0031
434 TOOTH FRACTURE 34 0.0031
435 IMPAIRED DRIVING ABILITY 35 0.0031
436 DEVICE MALFUNCTION 216 0.0031
437 KNEE OPERATION 30 0.0030
438 HEART RATE ABNORMAL 17 0.0030
439 LOCAL SWELLING 53 0.0030
440 UROSEPSIS 28 0.0030
441 FOOT OPERATION 15 0.0030
442 BLEPHAROSPASM 19 0.0030
443 PALLOR 82 0.0030
444 ANEURYSM 15 0.0030
445 HIP ARTHROPLASTY 46 0.0030
446 ALOPECIA 587 0.0030
447 POST-TRAUMATIC STRESS DISORDER 20 0.0030
448 LIMB INJURY 81 0.0030
449 ROTATOR CUFF SYNDROME 38 0.0030
450 HIP SURGERY 16 0.0030
451 DRUG INEFFECTIVE 3892 0.0030
452 MALAISE 1293 0.0029
453 CRYING 107 0.0029
454 ROAD TRAFFIC ACCIDENT 123 0.0029
455 NERVOUSNESS 153 0.0029
456 INABILITY TO AFFORD MEDICATION 29 0.0029
457 SKIN LESION 80 0.0029
458 TONGUE DISORDER 21 0.0029
459 DRUG EFFECT DECREASED 156 0.0029
460 APPENDICITIS 27 0.0029
461 HEPATIC ENZYME INCREASED 197 0.0029
462 MENTAL IMPAIRMENT 70 0.0029
463 STREPTOCOCCAL INFECTION 16 0.0029
464 PHOTOPHOBIA 54 0.0029
465 HEADACHE 1798 0.0029
466 UTERINE CANCER 23 0.0029
467 LEUKAEMIA 27 0.0029
468 TINNITUS 131 0.0028
469 CONDITION AGGRAVATED 862 0.0028
470 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 132 0.0028
471 ABSCESS 45 0.0028
472 POOR VENOUS ACCESS 29 0.0028
473 PERSONALITY CHANGE 26 0.0028
474 VENTRICULAR SEPTAL DEFECT 16 0.0028
475 HYPERSOMNIA 80 0.0028
476 EAR PAIN 54 0.0028
477 DRUG SPECIFIC ANTIBODY PRESENT 18 0.0028
478 OROPHARYNGEAL DISCOMFORT 25 0.0028
479 BRADYPHRENIA 18 0.0028
480 PIGMENTATION DISORDER 17 0.0028
481 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 47 0.0027
482 URINE ODOUR ABNORMAL 16 0.0027
483 PYREXIA 938 0.0027
484 NERVE COMPRESSION 25 0.0027
485 TACHYCARDIA 240 0.0027
486 BRAIN INJURY 27 0.0027
487 QUALITY OF LIFE DECREASED 36 0.0027
488 BREAST CANCER 250 0.0027
489 INFLUENZA 299 0.0027
490 FEELING JITTERY 51 0.0027
491 PRODUCT LEAKAGE 15 0.0027
492 MUSCLE STRAIN 23 0.0027
493 ASPIRATION 29 0.0026
494 HIP FRACTURE 85 0.0026
495 BODY TEMPERATURE DECREASED 26 0.0026
496 INITIAL INSOMNIA 27 0.0026
497 INCOHERENT 17 0.0026
498 HYPERTONIA 15 0.0026
499 COLON CANCER 39 0.0026
500 HERPES SIMPLEX 17 0.0026
501 LIVER FUNCTION TEST INCREASED 56 0.0026
502 INSOMNIA 694 0.0026
503 HERPES VIRUS INFECTION 15 0.0026
504 DEAFNESS 68 0.0026
505 THYROID DISORDER 40 0.0026
506 EPILEPSY 79 0.0026
507 EYELID OEDEMA 30 0.0026
508 BACK INJURY 28 0.0026
509 PELVIC FRACTURE 20 0.0026
510 ORAL HERPES 50 0.0026
511 DEVICE DELIVERY SYSTEM ISSUE 70 0.0026
512 RASH MACULAR 89 0.0025
513 NO THERAPEUTIC RESPONSE 31 0.0025
514 BREAST MASS 17 0.0025
515 DYSGEUSIA 188 0.0025
516 VISUAL ACUITY REDUCED 83 0.0025
517 AFFECT LABILITY 24 0.0025
518 HEART RATE DECREASED 87 0.0025
519 DYSPHAGIA 235 0.0025
520 PRODUCT USE COMPLAINT 39 0.0025
521 NASOPHARYNGITIS 456 0.0025
522 KNEE ARTHROPLASTY 52 0.0025
523 IMPAIRED HEALING 81 0.0025
524 SLEEP APNOEA SYNDROME 47 0.0025
525 BACK DISORDER 40 0.0025
526 STAPHYLOCOCCAL INFECTION 81 0.0025
527 EYE PAIN 138 0.0024
528 NAUSEA 1931 0.0024
529 EXTRASYSTOLES 17 0.0024
530 VOMITING 1142 0.0024
531 MUSCULOSKELETAL PAIN 127 0.0024
532 ELECTROCARDIOGRAM ABNORMAL 19 0.0024
533 DYSURIA 89 0.0024
534 HEPATIC STEATOSIS 45 0.0024
535 IMMUNODEFICIENCY 36 0.0024
536 INCORRECT ROUTE OF DRUG ADMINISTRATION 86 0.0024
537 PERIPHERAL SWELLING 369 0.0024
538 INCREASED TENDENCY TO BRUISE 22 0.0024
539 ULCER 38 0.0024
540 INTERVERTEBRAL DISC DEGENERATION 22 0.0024
541 AUTOIMMUNE DISORDER 23 0.0024
542 RHINITIS 19 0.0024
543 CARPAL TUNNEL SYNDROME 33 0.0024
544 MIDDLE INSOMNIA 44 0.0024
545 STENT PLACEMENT 19 0.0024
546 MOOD ALTERED 64 0.0023
547 IMPAIRED WORK ABILITY 50 0.0023
548 NEPHROTIC SYNDROME 16 0.0023
549 EAR INFECTION 62 0.0023
550 UNRESPONSIVE TO STIMULI 60 0.0023
551 VIRAL INFECTION 77 0.0023
552 BLOOD PRESSURE ABNORMAL 46 0.0023
553 HEPATITIS ACUTE 15 0.0023
554 LIVER FUNCTION TEST ABNORMAL 67 0.0023
555 DISORIENTATION 91 0.0023
556 GENERALISED TONIC-CLONIC SEIZURE 38 0.0023
557 PULMONARY THROMBOSIS 25 0.0023
558 RASH 988 0.0023
559 RENAL PAIN 24 0.0023
560 CYST 28 0.0023
561 ANGIOEDEMA 99 0.0022
562 SKIN INFECTION 25 0.0022
563 SHOCK 51 0.0022
564 THROAT IRRITATION 99 0.0022
565 RETCHING 47 0.0022
566 PETECHIAE 23 0.0022
567 CONFUSIONAL STATE 356 0.0022
568 SUICIDAL IDEATION 200 0.0022
569 NEOPLASM 25 0.0022
570 DYSKINESIA 88 0.0022
571 SPINAL OSTEOARTHRITIS 19 0.0022
572 BLOOD URINE PRESENT 41 0.0022
573 MYALGIA 366 0.0022
574 DISTURBANCE IN ATTENTION 116 0.0021
575 PURPURA 19 0.0021
576 FURUNCLE 17 0.0021
577 FOETAL EXPOSURE DURING PREGNANCY 173 0.0021
578 THERAPY INTERRUPTED 152 0.0021
579 PHARYNGITIS STREPTOCOCCAL 23 0.0021
580 SINUS DISORDER 42 0.0021
581 HAND FRACTURE 15 0.0021
582 GENERALISED OEDEMA 26 0.0021
583 RASH PRURITIC 113 0.0021
584 GASTRIC DISORDER 71 0.0021
585 NODULE 27 0.0021
586 APATHY 30 0.0021
587 BLOOD PRESSURE INCREASED 314 0.0021
588 MENSTRUAL DISORDER 17 0.0021
589 MUSCLE INJURY 17 0.0020
590 SKIN ULCER 53 0.0020
591 POOR QUALITY SLEEP 44 0.0020
592 VITREOUS FLOATERS 20 0.0020
593 SENSITIVE SKIN 15 0.0020
594 ATRIAL SEPTAL DEFECT 17 0.0020
595 ACCIDENT 24 0.0020
596 ABDOMINAL DISCOMFORT 336 0.0020
597 MUSCULOSKELETAL CHEST PAIN 31 0.0020
598 GASTROINTESTINAL PAIN 22 0.0020
599 JOINT STIFFNESS 52 0.0020
600 OROPHARYNGEAL PAIN 183 0.0020
601 VASCULITIS 23 0.0020
602 CLOSTRIDIUM DIFFICILE INFECTION 43 0.0020
603 JAUNDICE 53 0.0020
604 WEIGHT INCREASED 441 0.0020
605 DIZZINESS POSTURAL 19 0.0020
606 BOWEL MOVEMENT IRREGULARITY 15 0.0020
607 WHITE BLOOD CELL COUNT INCREASED 75 0.0020
608 GASTROINTESTINAL DISORDER 175 0.0020
609 COVID-19 341 0.0019
610 DECREASED IMMUNE RESPONSIVENESS 19 0.0019
611 FIBROMYALGIA 47 0.0019
612 HAEMATOMA 50 0.0019
613 SLEEP DISORDER 136 0.0019
614 BASAL CELL CARCINOMA 30 0.0019
615 SINUSITIS 197 0.0019
616 ANGER 65 0.0019
617 CHOLELITHIASIS 63 0.0019
618 FLANK PAIN 18 0.0019
619 RESPIRATORY RATE INCREASED 17 0.0019
620 ARTERIAL OCCLUSIVE DISEASE 15 0.0019
621 RESPIRATORY DISORDER 57 0.0019
622 HEART RATE IRREGULAR 43 0.0019
623 NEOPLASM MALIGNANT 127 0.0019
624 ORAL CANDIDIASIS 25 0.0019
625 TOOTH INFECTION 25 0.0019
626 BLOOD POTASSIUM DECREASED 57 0.0019
627 RASH ERYTHEMATOUS 90 0.0019
628 SCIATICA 30 0.0019
629 SURGERY 110 0.0019
630 ORAL PAIN 42 0.0019
631 THERAPY NON-RESPONDER 84 0.0019
632 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 378 0.0019
633 APHONIA 26 0.0019
634 ABDOMINAL PAIN UPPER 383 0.0019
635 STATUS EPILEPTICUS 21 0.0019
636 BLOOD IRON DECREASED 22 0.0019
637 BRONCHITIS 137 0.0018
638 GENERAL PHYSICAL HEALTH DETERIORATION 213 0.0018
639 DIVERTICULITIS 51 0.0018
640 SKIN LACERATION 20 0.0018
641 MENTAL DISORDER 80 0.0018
642 BLISTER 103 0.0018
643 HEPATOMEGALY 18 0.0018
644 EATING DISORDER 39 0.0018
645 LIVER DISORDER 81 0.0018
646 WOUND INFECTION 20 0.0018
647 MYOCARDIAL INFARCTION 318 0.0018
648 DEVICE DIFFICULT TO USE 120 0.0018
649 SKIN IRRITATION 83 0.0018
650 TREATMENT NONCOMPLIANCE 99 0.0018
651 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
652 BLOOD PRESSURE DECREASED 119 0.0018
653 INFECTION 259 0.0018
654 PRODUCT PACKAGING ISSUE 17 0.0018
655 EMOTIONAL DISORDER 55 0.0018
656 COVID-19 PNEUMONIA 21 0.0018
657 LOCALISED INFECTION 43 0.0018
658 HIATUS HERNIA 23 0.0018
659 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
660 NERVOUS SYSTEM DISORDER 55 0.0018
661 DERMATITIS ALLERGIC 22 0.0017
662 DISEASE RECURRENCE 83 0.0017
663 TENDONITIS 27 0.0017
664 SNEEZING 39 0.0017
665 WEIGHT DECREASED 485 0.0017
666 PYELONEPHRITIS 15 0.0017
667 PSYCHOTIC DISORDER 51 0.0017
668 BREAST CANCER FEMALE 46 0.0017
669 DEMENTIA 48 0.0017
670 GASTROENTERITIS 25 0.0017
671 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
672 INFLAMMATION 88 0.0017
673 THROMBOSIS 137 0.0017
674 COLITIS ULCERATIVE 76 0.0017
675 DYSPHONIA 99 0.0017
676 ARTHROPATHY 94 0.0017
677 DISEASE PROGRESSION 200 0.0017
678 BRONCHOSPASM 24 0.0017
679 DEHYDRATION 224 0.0017
680 BONE PAIN 98 0.0017
681 DRY THROAT 17 0.0017
682 TOOTH ABSCESS 17 0.0017
683 LETHARGY 96 0.0017
684 NASAL CONGESTION 98 0.0017
685 ARTHRALGIA 692 0.0017
686 BRAIN FOG 26 0.0017
687 SEPSIS 184 0.0016
688 EYE HAEMORRHAGE 22 0.0016
689 OCULAR HYPERAEMIA 78 0.0016
690 DEVICE FAILURE 25 0.0016
691 PNEUMOTHORAX 26 0.0016
692 CHROMATURIA 37 0.0016
693 CARDIAC DISORDER 153 0.0016
694 TRANSIENT ISCHAEMIC ATTACK 55 0.0016
695 HYPOACUSIS 70 0.0016
696 DRUG-INDUCED LIVER INJURY 51 0.0016
697 CARDIOMYOPATHY 24 0.0016
698 JOINT DISLOCATION 17 0.0016
699 BACTERIAL INFECTION 30 0.0016
700 TYPE 2 DIABETES MELLITUS 54 0.0016
701 OCULAR DISCOMFORT 18 0.0016
702 HYPERTENSION 339 0.0016
703 FUNGAL INFECTION 53 0.0016
704 UPPER RESPIRATORY TRACT INFECTION 73 0.0016
705 WHITE BLOOD CELL COUNT DECREASED 171 0.0016
706 DYSPEPSIA 155 0.0016
707 HEPATITIS C 19 0.0016
708 CEREBROVASCULAR ACCIDENT 266 0.0016
709 MOOD SWINGS 50 0.0016
710 PARANOIA 27 0.0016
711 HYPOTHYROIDISM 50 0.0016
712 EXPOSURE DURING PREGNANCY 97 0.0016
713 DRUG EXPOSURE DURING PREGNANCY 53 0.0016
714 GLAUCOMA 30 0.0016
715 OSTEOPOROSIS 64 0.0016
716 HERNIA 30 0.0015
717 HOSPITALISATION 238 0.0015
718 DIABETES MELLITUS 118 0.0015
719 DELUSION 24 0.0015
720 IMPAIRED GASTRIC EMPTYING 21 0.0015
721 SKIN CANCER 33 0.0015
722 FEEDING DISORDER 31 0.0015
723 RESPIRATORY DISTRESS 42 0.0015
724 HYPERTHYROIDISM 22 0.0015
725 LIVER INJURY 37 0.0015
726 ABDOMINAL DISTENSION 157 0.0015
727 SPINAL FRACTURE 30 0.0015
728 BLOOD TEST ABNORMAL 21 0.0015
729 OEDEMA PERIPHERAL 182 0.0015
730 HEPATIC FAILURE 45 0.0015
731 OSTEOMYELITIS 27 0.0015
732 LABORATORY TEST ABNORMAL 44 0.0015
733 NEUROPATHY PERIPHERAL 141 0.0015
734 CONSTIPATION 323 0.0015
735 PNEUMONIA ASPIRATION 37 0.0015
736 FRACTURE 28 0.0015
737 PULMONARY MASS 22 0.0015
738 BLOOD GLUCOSE FLUCTUATION 16 0.0015
739 CORONARY ARTERY OCCLUSION 20 0.0015
740 EXTRA DOSE ADMINISTERED 59 0.0015
741 DRY MOUTH 118 0.0015
742 PHOTOSENSITIVITY REACTION 24 0.0015
743 IRRITABILITY 87 0.0014
744 FOOT DEFORMITY 16 0.0014
745 INTENTIONAL DOSE OMISSION 41 0.0014
746 TOOTHACHE 26 0.0014
747 PNEUMONIA 464 0.0014
748 PULMONARY EMBOLISM 136 0.0014
749 RASH PAPULAR 32 0.0014
750 NIGHT SWEATS 46 0.0014
751 BRAIN OEDEMA 18 0.0014
752 ABDOMINAL PAIN 331 0.0014
753 DRUG ADMINISTERED AT INAPPROPRIATE SITE 15 0.0014
754 PANCREATITIS 75 0.0014
755 SEASONAL ALLERGY 20 0.0014
756 ABNORMAL DREAMS 39 0.0014
757 PAIN IN JAW 40 0.0014
758 ACCIDENTAL EXPOSURE TO PRODUCT 145 0.0014
759 SOMNOLENCE 282 0.0014
760 GALLBLADDER DISORDER 25 0.0014
761 THIRST 25 0.0014
762 IRRITABLE BOWEL SYNDROME 30 0.0014
763 COUGH 391 0.0014
764 TRANSAMINASES INCREASED 31 0.0014
765 TOOTH DISORDER 31 0.0014
766 VAGINAL HAEMORRHAGE 60 0.0014
767 INTESTINAL OBSTRUCTION 52 0.0014
768 PELVIC PAIN 25 0.0014
769 DIARRHOEA 888 0.0014
770 RENAL DISORDER 64 0.0014
771 ARTHRITIS 108 0.0014
772 ILL-DEFINED DISORDER 83 0.0014
773 PREMATURE BABY 41 0.0014
774 DRUG DOSE OMISSION BY DEVICE 106 0.0014
775 HAIR TEXTURE ABNORMAL 18 0.0013
776 PAIN OF SKIN 36 0.0013
777 ILLNESS 137 0.0013
778 HEPATITIS 34 0.0013
779 PRODUCT QUALITY ISSUE 180 0.0013
780 MITRAL VALVE INCOMPETENCE 15 0.0013
781 PREMATURE DELIVERY 21 0.0013
782 ABDOMINAL PAIN LOWER 33 0.0013
783 PRESCRIBED UNDERDOSE 26 0.0013
784 CARDIOVASCULAR DISORDER 33 0.0013
785 SYSTEMIC LUPUS ERYTHEMATOSUS 46 0.0013
786 ORAL DISCOMFORT 18 0.0013
787 ANGINA PECTORIS 37 0.0013
788 SARS-COV-2 TEST POSITIVE 17 0.0013
789 TOOTH EXTRACTION 16 0.0013
790 DRUG EFFECT LESS THAN EXPECTED 19 0.0013
791 MENINGIOMA 20 0.0013
792 MENORRHAGIA 25 0.0013
793 INCORRECT DOSE ADMINISTERED 290 0.0013
794 WRONG TECHNIQUE IN DRUG USAGE PROCESS 46 0.0013
795 LUNG NEOPLASM MALIGNANT 52 0.0013
796 PRODUCT DOSE OMISSION ISSUE 371 0.0013
797 RED BLOOD CELL COUNT DECREASED 36 0.0013
798 HALLUCINATION, AUDITORY 20 0.0013
799 RESTLESSNESS 46 0.0013
800 OSTEOARTHRITIS 53 0.0012
801 BLOOD PRESSURE FLUCTUATION 30 0.0012
802 DRUG EFFECT INCOMPLETE 45 0.0012
803 BURSITIS 15 0.0012
804 PRODUCT STORAGE ERROR 107 0.0012
805 FLUID RETENTION 62 0.0012
806 LEUKOCYTOSIS 22 0.0012
807 GASTRIC ULCER 23 0.0012
808 RHINORRHOEA 78 0.0012
809 TOOTH LOSS 25 0.0012
810 ALANINE AMINOTRANSFERASE INCREASED 74 0.0012
811 UNEVALUABLE EVENT 91 0.0012
812 DEEP VEIN THROMBOSIS 78 0.0012
813 METASTASES TO LIVER 21 0.0012
814 GASTROOESOPHAGEAL REFLUX DISEASE 96 0.0012
815 RESPIRATORY TRACT INFECTION 31 0.0012
816 SUICIDE ATTEMPT 72 0.0012
817 TASTE DISORDER 24 0.0012
818 IMPAIRED QUALITY OF LIFE 17 0.0012
819 OEDEMA 64 0.0012
820 UVEITIS 16 0.0012
821 BLOOD SODIUM DECREASED 22 0.0012
822 EJECTION FRACTION DECREASED 18 0.0012
823 BONE DISORDER 21 0.0012
824 ASPARTATE AMINOTRANSFERASE INCREASED 61 0.0011
825 PRODUCT AVAILABILITY ISSUE 26 0.0011
826 JOINT SWELLING 137 0.0011
827 BLOOD PRESSURE SYSTOLIC INCREASED 22 0.0011
828 CATARACT 67 0.0011
829 OSTEOPENIA 17 0.0011
830 HEPATIC CIRRHOSIS 21 0.0011
831 GOUT 20 0.0011
832 SINUS CONGESTION 15 0.0011
833 PRODUCT DISPENSING ERROR 24 0.0011
834 ACUTE HEPATIC FAILURE 15 0.0011
835 HALLUCINATION, VISUAL 23 0.0011
836 PRODUCT ADMINISTRATION ERROR 22 0.0011
837 AGITATION 79 0.0011
838 SKIN BURNING SENSATION 77 0.0011
839 CANDIDA INFECTION 18 0.0011
840 DEVICE OCCLUSION 15 0.0011
841 HYPOTENSION 213 0.0011
842 CEREBRAL HAEMORRHAGE 38 0.0011
843 HAEMATOCRIT DECREASED 21 0.0011
844 BLOOD COUNT ABNORMAL 16 0.0011
845 COMA 50 0.0010
846 OXYGEN SATURATION DECREASED 59 0.0010
847 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 189 0.0010
848 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
849 GAMMA-GLUTAMYLTRANSFERASE INCREASED 23 0.0010
850 OSTEONECROSIS 34 0.0010
851 FEMUR FRACTURE 32 0.0010
852 AMENORRHOEA 18 0.0010
853 HAEMORRHAGE 107 0.0010
854 HALLUCINATION 77 0.0010
855 PRODUCT USE ISSUE 191 0.0010
856 MENTAL STATUS CHANGES 28 0.0010
857 AGEUSIA 25 0.0010
858 DERMATITIS 21 0.0010
859 MOUTH ULCERATION 21 0.0010
860 INCREASED APPETITE 19 0.0010
861 WHEEZING 58 0.0010
862 METASTASES TO BONE 16 0.0010
863 ASTHMA 110 0.0010
864 MANIA 16 0.0010
865 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
866 GASTRITIS 25 0.0009
867 DRUG INTERACTION 150 0.0009
868 DRUG ADMINISTRATION ERROR 29 0.0009
869 OBESITY 15 0.0009
870 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 49 0.0009
871 LUNG DISORDER 46 0.0009
872 THERAPEUTIC PRODUCT EFFECT DECREASED 42 0.0009
873 DECREASED APPETITE 217 0.0009
874 MENSTRUATION IRREGULAR 25 0.0009
875 ERUCTATION 18 0.0009
876 LOWER RESPIRATORY TRACT INFECTION 42 0.0009
877 HAEMORRHOIDS 18 0.0009
878 ORTHOSTATIC HYPOTENSION 16 0.0009
879 PRODUCT DOSE OMISSION IN ERROR 26 0.0009
880 BLOOD GLUCOSE DECREASED 44 0.0009
881 ARRHYTHMIA 43 0.0009
882 DEATH 778 0.0009
883 COLITIS 34 0.0009
884 PRODUCT PHYSICAL ISSUE 18 0.0009
885 CARDIAC ARREST 73 0.0009
886 ABNORMAL BEHAVIOUR 35 0.0009
887 BLOOD CHOLESTEROL INCREASED 41 0.0009
888 DYSTONIA 17 0.0009
889 EXPIRED PRODUCT ADMINISTERED 29 0.0009
890 NIGHTMARE 30 0.0009
891 CONJUNCTIVITIS 16 0.0009
892 HAEMATOCHEZIA 47 0.0009
893 UNDERDOSE 62 0.0008
894 GLOSSODYNIA 19 0.0008
895 DRY EYE 42 0.0008
896 BLOOD CREATINE PHOSPHOKINASE INCREASED 24 0.0008
897 FAECES DISCOLOURED 18 0.0008
898 CARDIAC FAILURE CONGESTIVE 66 0.0008
899 ACCIDENTAL OVERDOSE 30 0.0008
900 APPLICATION SITE PAIN 18 0.0008
901 BLOOD BILIRUBIN INCREASED 22 0.0008
902 ACNE 61 0.0008
903 LEUKOPENIA 40 0.0008
904 AGGRESSION 40 0.0008
905 PROTEINURIA 15 0.0008
906 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 43 0.0008
907 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
908 RENAL FAILURE 104 0.0008
909 FREQUENT BOWEL MOVEMENTS 21 0.0008
910 ENCEPHALOPATHY 19 0.0008
911 SKIN EXFOLIATION 65 0.0008
912 ATRIAL FIBRILLATION 74 0.0008
913 EPISTAXIS 56 0.0007
914 EYE PRURITUS 25 0.0007
915 CEREBRAL INFARCTION 18 0.0007
916 HAEMATURIA 25 0.0007
917 APPLICATION SITE ERYTHEMA 19 0.0007
918 RECTAL HAEMORRHAGE 31 0.0007
919 STEVENS-JOHNSON SYNDROME 16 0.0007
920 HEPATOTOXICITY 16 0.0007
921 OESOPHAGEAL CARCINOMA 21 0.0007
922 INTENTIONAL PRODUCT MISUSE 62 0.0007
923 ERECTILE DYSFUNCTION 18 0.0007
924 INFUSION RELATED REACTION 46 0.0007
925 PERICARDIAL EFFUSION 16 0.0007
926 GLYCOSYLATED HAEMOGLOBIN INCREASED 17 0.0007
927 LACRIMATION INCREASED 20 0.0007
928 PANCREATIC CARCINOMA 19 0.0007
929 FLATULENCE 37 0.0007
930 HYPOKALAEMIA 30 0.0006
931 PROCEDURAL PAIN 18 0.0006
932 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 46 0.0006
933 HAEMOPTYSIS 18 0.0006
934 BRADYCARDIA 34 0.0006
935 RESPIRATORY FAILURE 46 0.0006
936 HYPOPHAGIA 16 0.0006
937 CARDIAC FAILURE 50 0.0006
938 EXPOSURE VIA SKIN CONTACT 16 0.0006
939 HEPATIC FUNCTION ABNORMAL 23 0.0006
940 INJURY 43 0.0006
941 ECZEMA 32 0.0006
942 PLEURAL EFFUSION 37 0.0006
943 CORONARY ARTERY DISEASE 18 0.0006
944 ANHEDONIA 15 0.0006
945 EMOTIONAL DISTRESS 68 0.0006
946 CONTRAINDICATED PRODUCT ADMINISTERED 17 0.0006
947 PULMONARY OEDEMA 25 0.0006
948 HAEMOGLOBIN DECREASED 57 0.0006
949 PRODUCT USE IN UNAPPROVED INDICATION 137 0.0006
950 C-REACTIVE PROTEIN INCREASED 20 0.0005
951 PRODUCTIVE COUGH 26 0.0005
952 ANAEMIA 103 0.0005
953 BLOOD GLUCOSE INCREASED 101 0.0005
954 THERAPEUTIC RESPONSE DECREASED 32 0.0005
955 INTENTIONAL PRODUCT USE ISSUE 46 0.0005
956 RENAL CANCER 25 0.0005
957 WITHDRAWAL SYNDROME 22 0.0005
958 RENAL FAILURE ACUTE 22 0.0005
959 STOMATITIS 31 0.0005
960 ASCITES 15 0.0005
961 ACUTE MYOCARDIAL INFARCTION 15 0.0005
962 CARDIO-RESPIRATORY ARREST 21 0.0005
963 OFF LABEL USE 436 0.0005
964 DELIRIUM 17 0.0005
965 DRY SKIN 65 0.0005
966 MEDICATION ERROR 27 0.0005
967 PROSTATE CANCER 39 0.0005
968 RENAL IMPAIRMENT 39 0.0005
969 HYPONATRAEMIA 26 0.0005
970 PLATELET COUNT DECREASED 48 0.0004
971 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
972 DEVICE USE ERROR 15 0.0004
973 PSORIATIC ARTHROPATHY 17 0.0004
974 EYE IRRITATION 24 0.0004
975 SEPTIC SHOCK 18 0.0004
976 DRUG WITHDRAWAL SYNDROME 35 0.0004
977 OVERDOSE 82 0.0004
978 BLADDER CANCER 22 0.0004
979 HYPOGLYCAEMIA 18 0.0004
980 BLOOD CREATININE INCREASED 22 0.0003
981 THROMBOCYTOPENIA 36 0.0003
982 RHEUMATOID ARTHRITIS 36 0.0003
983 PSORIASIS 41 0.0003
984 COMPLETED SUICIDE 25 0.0003
985 PANCYTOPENIA 15 0.0003
986 ACUTE KIDNEY INJURY 39 0.0003
987 NEUTROPENIA 34 0.0002
988 NO ADVERSE EVENT 44 0.0002
989 CHRONIC KIDNEY DISEASE 18 0.0002
990 TOXICITY TO VARIOUS AGENTS 25 0.0001
991 DRUG DEPENDENCE 19 0.0001